wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37364393-6553E2E6-5FF6-4132-8E41-C341EA59BFCC
Q37364393-6553E2E6-5FF6-4132-8E41-C341EA59BFCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37364393-6553E2E6-5FF6-4132-8E41-C341EA59BFCC
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study.
P2860
Q37364393-6553E2E6-5FF6-4132-8E41-C341EA59BFCC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37364393-6553E2E6-5FF6-4132-8E41-C341EA59BFCC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c53fa58e89d6722df587cc5f0ce063a3ecc718bb
P2860
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia